Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s12185-020-02931-9 http://scihub22266oqcxt.onion/10.1007/s12185-020-02931-9 32613314!7327458!32613314     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=32613314&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Int+J+Hematol 2020 ; 112 (5): 746-750 Nephropedia Template TP {{tp|p=32613314|t=2020. Severe immune thrombocytopenic purpura in critical COVID-19 |pdf=|usr=}}{{32613314}} gab.com Text Severe immune thrombocytopenic purpura in critical COVID-19 JO: Int J Hematol http://www.kidney.de/pget.php?&tw=1&pmid=32613314 #FOAvip COVID-19 is a new disease with many undescribed clinical manifestations. We report herein a case of severe immune thrombocytopenic purpura (ITP) in a critical COVID-19 patient. A patient presented a severe episode of immune thrombocytopenia (< 10 x 10(9)/L) 20 days after admission for a critical COVID-19. This thrombocytopenia was associated with a life-threatening bleeding. Response to first-line therapies was delayed as it took up to 13 days after initiation of intravenous immunoglobulin and high-dose dexamethasone to observe an increase in platelet count. COVID-19 may be associated with late presenting severe ITP. Such ITP may also be relatively resistant to first-line agents. Hematological manifestations of COVID-19, such as the ones associated with life-threatening bleeding, must be recognized. Twit Text FOAVip Severe immune thrombocytopenic purpura in critical COVID-19 ????Int J Hematol http://www.kidney.de/pget.php?&tw=1&pmid=32613314 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32613314 #FOAvip English Wikipedia <ref>{{Cite pmid|32613314}}</ref> Severe immune thrombocytopenic purpura in critical COVID-19 #MMPMID32613314 Levesque V; Millaire E; Corsilli D; Rioux-Masse B; Carrier FM Int J Hematol 2020[Nov]; 112 (5): 746-750 PMID32613314show ga COVID-19 is a new disease with many undescribed clinical manifestations. We report herein a case of severe immune thrombocytopenic purpura (ITP) in a critical COVID-19 patient. A patient presented a severe episode of immune thrombocytopenia (< 10 x 10(9)/L) 20 days after admission for a critical COVID-19. This thrombocytopenia was associated with a life-threatening bleeding. Response to first-line therapies was delayed as it took up to 13 days after initiation of intravenous immunoglobulin and high-dose dexamethasone to observe an increase in platelet count. COVID-19 may be associated with late presenting severe ITP. Such ITP may also be relatively resistant to first-line agents. Hematological manifestations of COVID-19, such as the ones associated with life-threatening bleeding, must be recognized. |*Pandemics[MESH] |Betacoronavirus[MESH] |COVID-19[MESH] |COVID-19 Drug Treatment[MESH] |Combined Modality Therapy[MESH] |Coronavirus Infections/*complications/drug therapy[MESH] |Dexamethasone/therapeutic use[MESH] |Hemorrhage/etiology[MESH] |Humans[MESH] |Immunoglobulins, Intravenous[MESH] |Intracranial Hemorrhages/etiology[MESH] |Male[MESH] |Middle Aged[MESH] |Pneumonia, Staphylococcal/etiology[MESH] |Pneumonia, Ventilator-Associated/etiology[MESH] |Pneumonia, Viral/*complications[MESH] |Pulmonary Atelectasis/etiology[MESH] |Purpura, Thrombocytopenic, Idiopathic/drug therapy/*etiology/therapy[MESH] |Respiratory Distress Syndrome/etiology/therapy[MESH]Severe immune thrombocytopenic purpura in critical COVID-19 (epmc).pdf DeepDyve Pubget Overpricing